产品中心
PRODUCTS
产品简介
名称:Recombinant human APOE4货号:UN545规格:100μg/500μg纯度:>97%系统:E.coli.产品详情Recombinant human APOE4ApoE is a major protein component of serum LDL, VLDL, HDL, and chylomicrons. It is produced predominantly by hepatocytes, macrophages, and nonneuronal cells in the CNS. ApoEconta
名称:Recombinant human APOE4
货号:UN545
规格:100μg/500μg
纯度:>97%
系统:E.coli.
产品详情
Recombinant human APOE4
ApoE is a major protein component of serum LDL, VLDL, HDL, and chylomicrons. It is produced predominantly by hepatocytes, macrophages, and nonneuronal cells in the CNS. ApoEcontaining particles transport triglycerides and cholesterol to peripheral tissues for cellular uptake and catabolism. Mature human ApoE is a 34kDa glycoprotein that consists of an Nterminal domain composed of four bundled αhelices, plus a hinge region and an extended αhelical C-terminal domain. Its amphipathic nature and flexible structure enable it to adopt dramatically different conformations upon lipid association. ApoE is monomeric in lipid particle, although it forms Homotetramer when lipid free.
Mature human ApoE shares 71% aa sequence identity with mouse and rat ApoE. ApoE is an important constituent of all plasma lipoproteins. Its interaction with specific ApoE receptor enables uptake of chylomicron remnants by liver cells, which is an essential step during normal lipid metabolism. It also binds with the LDL receptor (apo B/E). Defects in ApoE are a cause of hyperlipoproteinemia type III. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. E3 is the most common isoform and is present in 40-90% of the population.
名称缩写/Abbreviation:
APOE4
货号/Item No.:
UN545
别名/Synonyms:
Apolipoprotein E,APOE,Apo-E
表达系统/Source:
Expressed in E. coli.
分子量/Molecular Weight:
Approximately 34.3 kDa, a single non-glycosylated polypeptide chain containing 299 amino acids.
SCI的检索号/Accession #:
P02649 Lys19-His317
蛋白序列/A.A. Sequence:
KVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVRGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH
纯度/Purity:
>97% by SDS-PAGE or HPLC., >96% by SDS-PAGE or HPLC.
活性/Biological Activity:
Fully biologically active when compared to standard. Determined by its ability to stimulate the proliferation of human SH-SY5Y cells, The ED₅₀ for this effect is ≤8.75ng/ml. corresponding to a specific activity is ≥1.15×10⁵ units/mg.
配方/Formulation:
Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, with 150 mM NaCl pH 7.4.
外观/Appearance:
Sterile filtered White lyophilized (freeze-dried) powder.
内毒素/Endotoxin:
< 1 EU/μg of rHuPTH7-84 protein as determined by LAL method.
复溶/Reconstitution:
Before use this product, please read the direction below carefully. This vial must be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in a sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20℃. Further dilutions should be made in appropriate buffered solutions.
稳定性和存储/Stability & Storage:
For long term storage, the product should be stored ≤ -20℃. Please avoid repeated freeze-thaw cycles after reconstitution. 36 months from date of receipt, -20 to -70℃ as supplied. 1 month, 2 to 8℃ under sterile conditions after reconstitution. 3 months, -20 to -70℃ under sterile conditions after reconstitution.
* THIS PRODUCT IS FOR RESEARCH, LABORATORY AND EVALUATION PURPOSE ONLY.